2016 International Congress

Tuesday, June 21, 2016

12:30pm-2:00pm

Objective movement recording in PD patient before and after STN-DBS

D. Flisar, B. Pikš, B. Meglic, Z. Pirtošek, G. Kramberger (Ljubljana, Slovenia)

Technology  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Oculopalatal myoclonus after stroke

B. Klysz, I. Sarzynska-Dlugosz, A. Czlonkowska, I. Kurkowska-Jastrzebska (Warsaw, Poland)

Myoclonus  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Olfaction and gray matter volume in Parkinson’s disease. A voxel-based morphometry study

K. Witt, N. Schmidt, O. Granert, L. Paschen, S. Wolff, G. Deuschl (Kiel, Germany)

Parkinson's disease: Pathophysiology  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Oligomeric alpha-synuclein and glucocerebrosidase activity levels in GBA-associated Parkinson’s disease

A.K. Emelyanov, G.V. Baydakova, P.A. Andoskin, M.A. Nikolaev, K.A. Senkevich, I.V. Milyukhina, A.F. Yakimovskii, A.A. Timofeeva, E.Y. Fedotova, E.P. Nuzhnyi, S.N. Illarioshkin, E.Y. Zakharova, S.N. Pchelina (Saint-Petersburg, Russia)

Parkinson's disease: Genetics  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Opioid K receptor variant delays the onset of dyskinesias in Parkinson’s disease

R. Cilia, R. Asselta, R. Benfante, E. Cereda, D. Vallauri, L. Marabini, D. Fornasari, S. Goldwurm, G. Pezzoli (Milan, Italy)

Parkinson's disease: Pathophysiology  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Opsoclonus myoclonus ataxia syndrome in a seronegative patient with disseminated cryptococcosis: The first case report

K. Sakdisornchai, J. Sringean, O. Jitkritsadakul, R. Bhidayasiri (Bangkok, Thailand)

Myoclonus  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Optimization of 6-hydroxydopamine animal model of early stage Parkinson´s disease for the assessment of neurorestorative therapies

J.V. Leikas, T.M. Kääriäinen, A.J. Jalkanen, M. Lehtonen, T. Rantamäki, M.M. Forsberg (Kuopio, Finland)

Parkinson's disease: Pathophysiology  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Oral apomorphine film (APL-130277) produces no buccal mucosal irritation: Results of a toxicological study

A. Agro, B. Dzyngel, T. Bilbault, E.J. Pappert (Toronto, ON, Canada)

Parkinson's disease: Pathophysiology  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Orthostatic tremor: A literature review of clinical data

D.E. Bhatti, D. Torres-Russotto (Omaha, NE, USA)

Tremor  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Orthostatic tremor: Disease progression and disability

N. Vijiaratnam, D. Siresena, E. Paul, K.L. Bertram, D.R. Williams (Melbourne, Australia)

Tremor  ·  Exhibit Hall located in Hall B, Level 2